NO961901D0 - 6-okso-nucleosider som er anvendbare immunoundertrykkende midler - Google Patents

6-okso-nucleosider som er anvendbare immunoundertrykkende midler

Info

Publication number
NO961901D0
NO961901D0 NO961901A NO961901A NO961901D0 NO 961901 D0 NO961901 D0 NO 961901D0 NO 961901 A NO961901 A NO 961901A NO 961901 A NO961901 A NO 961901A NO 961901 D0 NO961901 D0 NO 961901D0
Authority
NO
Norway
Prior art keywords
nucleosides
oxo
useful immunosuppressants
immunosuppressants
useful
Prior art date
Application number
NO961901A
Other languages
English (en)
Other versions
NO961901L (no
Inventor
David Roger Borcherding
Iii Carl Keith Edwards
Alexey Leonid Margolin
Serge Halazy
Anne Eggenspiller
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO961901D0 publication Critical patent/NO961901D0/no
Publication of NO961901L publication Critical patent/NO961901L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO961901A 1993-11-12 1996-05-10 6-okso-nucleosider som er anvendbare immunoundertrykkende midler NO961901L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15108893A 1993-11-12 1993-11-12
PCT/US1994/011778 WO1995013277A1 (en) 1993-11-12 1994-10-13 6-oxo-nucleosides useful as immunosuppressants

Publications (2)

Publication Number Publication Date
NO961901D0 true NO961901D0 (no) 1996-05-10
NO961901L NO961901L (no) 1996-07-11

Family

ID=22537266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961901A NO961901L (no) 1993-11-12 1996-05-10 6-okso-nucleosider som er anvendbare immunoundertrykkende midler

Country Status (12)

Country Link
EP (1) EP0728134A1 (no)
JP (1) JPH09509397A (no)
KR (1) KR960705825A (no)
CN (1) CN1137274A (no)
AU (1) AU677732B2 (no)
CA (1) CA2175897A1 (no)
FI (1) FI962010A (no)
HU (1) HUT74989A (no)
IL (1) IL111544A0 (no)
NO (1) NO961901L (no)
WO (1) WO1995013277A1 (no)
ZA (1) ZA948591B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717160B2 (en) * 1994-06-22 2000-03-16 Shire Canada Inc. Novel substituted purinyl derivatives with immunomodulating activity
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
US6859652B2 (en) 2000-08-02 2005-02-22 Mobile Satellite Ventures, Lp Integrated or autonomous system and method of satellite-terrestrial frequency reuse using signal attenuation and/or blockage, dynamic assignment of frequencies and/or hysteresis
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164556B (no) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
IT1229531B (it) * 1988-01-20 1991-09-04 Univ Minnesota Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
AU647822B2 (en) * 1990-09-14 1994-03-31 Marion Merrell Dow Inc. Novel carbocyclic adenosine analogs useful as immunosuppressants

Also Published As

Publication number Publication date
FI962010A (fi) 1996-07-10
HU9601262D0 (en) 1996-07-29
WO1995013277A1 (en) 1995-05-18
NO961901L (no) 1996-07-11
AU8120794A (en) 1995-05-29
ZA948591B (en) 1995-06-23
CN1137274A (zh) 1996-12-04
HUT74989A (en) 1997-03-28
IL111544A0 (en) 1995-01-24
KR960705825A (ko) 1996-11-08
CA2175897A1 (en) 1995-05-18
FI962010A0 (fi) 1996-05-10
AU677732B2 (en) 1997-05-01
EP0728134A1 (en) 1996-08-28
JPH09509397A (ja) 1997-09-22

Similar Documents

Publication Publication Date Title
FI931229A (fi) Som glanspigment laempade blandningar
FI933167A0 (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
FI921182A (fi) Velangummi som snabbt hydratiseras
FI931069A (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
FI930271A (fi) Katjonbytehartser som har foeroekad kapasitet foer jaernoxider
FI932741A0 (fi) Mjukvaevnadsfilteranordning till kefalostat
FI933022A0 (fi) Radiosystem som bildar en traodloes lokalslinga
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
FI933834A0 (fi) Polsko till en magnetografisk avbildningsapparat
NO961901D0 (no) 6-okso-nucleosider som er anvendbare immunoundertrykkende midler
FI930342A0 (fi) Pentapeptider som reglerar immun- och nervsystem
FI810U1 (fi) Staell som underlaettar mattvaett
FI934401A0 (fi) Lufttillfoerselsystem som hindrar milfoerbraenning
FI931598A0 (fi) Spelbraede foer som bokstavplattor formade spelbrickor
FI930018A0 (fi) Staell som underlaettar mattvaett
FI930528A0 (fi) Luftkuddskonstruktion som passagerarskydd i fordon
FI933314A0 (fi) Foerfarande foer framstaellning av fiberspaon som raomaterial till en starkpapperssort
FI934219A0 (fi) Foerbandsbalkkonstruktion som huvudsaklig baerare foer mellanbjaelklag i flervaeningshus (tt-foerbandsbalk)
FI932312A0 (fi) Anordning som underlaettar borstning av taender
FI933315A0 (fi) Anordning som underlaettar plockning av jordgubbar
FI935925A0 (fi) Fortskaffningsmedel som utfoer tvaofasroerelse med hjaelp av en ledemekanism
FI361U1 (fi) Loestagbar barnstol som tillaeggsutrustning till koekstrappa
FI930917A0 (fi) Uppsamling pao brunnbrickor av tritium- och 14c-prov som erhaollits fraonprovfoerbraenningsanordning
FI931467A0 (fi) Torr enkomponent ytskiktsmaterial som innehaoller silikater
FIU950183U0 (fi) Faerdiggraeddad matsporation avsedd att foertaeras som engaongsportion